To Compare the Efficacy and Patients' Satisfaction for the Treatment of Post Cesarean Pain of Two Protocols: Oral Medications in Fixed Time Interval Administration Versus Spinal Morphine

NCT ID: NCT02440399

Last Updated: 2017-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cesarean deliveries are prevalent. Unlike other operations, quick recovery is required for the mother to nurture the newborn child and establishing an appropriate mother-child bonding.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cesarean deliveries are prevalent. Unlike other operations, quick recovery is required for the mother to nurture the newborn child and establishing an appropriate mother-child bonding. Therefore, effective pain management is crucial. In this study we would like to compare between two pain relievers' administration protocols:

1. Oral pain relievers' administration in fix protocol without need for patient demand
2. Spinal morphine given during the spinal anesthesia in the cesarean section

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Cesarean Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fix protocol - Oral treatment

During 48 hours following surgery pain medications will be given as followed (listed in brackets are the generic names of each medication):

At patient arrival to the department: Intravenous Tramadol hydrochloride 100 milligrams + TAB. Paracetamol 500 milligrams + TAB. Diclofenac 100 milligrams

After 6 hours from patient arrival and every 6 hours: TAB. Zaldiar (Paracetamol 650 milligrams + Tramadol 75 milligrams).

After 12, 24 and 48 hours from patient arrival: TAB. Diclofenac 100 milligrams.

Rescue medication: TAB. Percocet (Oxycodone 5MG/Paracetamol 325 MG)as necessary up to 4 times per day.

The total amount of paracetamol is limited to 4 gr per day.

Group Type EXPERIMENTAL

Tramadol hydrochloride

Intervention Type DRUG

Please see arm description

Paracetamol

Intervention Type DRUG

Diclofenac

Intervention Type DRUG

TAB. Percocet (Oxycodone 5MG/Paracetamol 325 MG)

Intervention Type DRUG

Spinal morphine

The women will receive 150 mcg morphine with the spinal anesthesia given in the cesarean section

Group Type EXPERIMENTAL

Morphine

Intervention Type DRUG

Please see arm description

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tramadol hydrochloride

Please see arm description

Intervention Type DRUG

Morphine

Please see arm description

Intervention Type DRUG

Paracetamol

Intervention Type DRUG

Diclofenac

Intervention Type DRUG

TAB. Percocet (Oxycodone 5MG/Paracetamol 325 MG)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women that underwent cesarean section with sinal anesthesia

Exclusion Criteria

* Women who suffer from chronic pain
* Women using chronic pain medications
* Women with allergy to any drug used in the study
* Women underwent general anesthesia during the surgery
* Women who suffer from sleep apnea
* Women who suffer from obesity (BMI\>40)
* Women who suffer from severe nausea and vomiting after previous surgery
* Women who received perioperative magnesium
* Women who suffer from hypertension
* Women who suffer from renal failure
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HaEmek Medical Center, Israel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

enav yefet

MD/PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haemek Medical Center

Afula, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

References

Explore related publications, articles, or registry entries linked to this study.

Yefet E, Nassar S, Carmeli J, Massalha M, Hasanein J, Zafran N, Rudin M, Nachum Z. Oral analgesia in fixed-time interval administration versus spinal morphine for post-Cesarean pain: a randomised controlled trial. Arch Gynecol Obstet. 2022 Apr;305(4):893-901. doi: 10.1007/s00404-021-06196-3. Epub 2021 Aug 31.

Reference Type DERIVED
PMID: 34463805 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0028-15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intrathecal Opioid Study
NCT02577809 COMPLETED PHASE4
Management Of Pain After Cesarean Trial
NCT03929640 TERMINATED PHASE3
Towards Enhanced Recovery After Cesarean
NCT04612920 COMPLETED EARLY_PHASE1